Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	OLIENA Language recovery after stroke App | Video | PDF (278 pp) | Web

Cytomegalovirus Infection

Free Subscription Articles published in J Clin Virol Retrieve available abstracts of 57 articles: HTML format Text format

Single Articles

May 2018
1. GOSHEN O, Goldfarb DM, Book L, Tilley P, et al
   Recovery of cytomegalovirus DNA from newborn saliva samples by different methods.
   J Clin Virol. 2018;104:73-76.
   PubMed     Text format     Abstract available
   
   
   April 2018
2. SHI TL, Huang LJ, Xiong YQ, Zhong YY, et al
   The risk of herpes simplex virus and human cytomegalovirus infection during pregnancy upon adverse pregnancy outcomes: A meta-analysis.
   J Clin Virol. 2018;104:48-55.
   PubMed     Text format     Abstract available
   
   
   
3. NAEGELE K, Lautenschlager I, Gosert R, Loginov R, et al
   Cytomegalovirus sequence variability, amplicon length, and DNase-sensitive non-encapsidated genomes are obstacles to standardization and commutability of plasma viral load results.
   J Clin Virol. 2018;104:39-47.
   PubMed     Text format     Abstract available
   
   
   
4. FURIONE M, Sarasini A, Arossa A, Fornara C, et al
   False human cytomegalovirus IgG-positivity at prenatal screening.
   J Clin Virol. 2018;104:34-38.
   PubMed     Text format     Abstract available
   
   
   March 2018
5. RAWLINSON WD, Palasanthiran P, Hall B, Al Yazidi L, et al
   Neonates with congenital Cytomegalovirus and hearing loss identified via the universal newborn hearing screening program.
   J Clin Virol. 2018;102:110-115.
   PubMed     Text format     Abstract available
   
   
   February 2018
6. SAM SS, Ingersoll J, Racsa LD, Caliendo AM, et al
   Long-term stability of CMV DNA in human breast milk.
   J Clin Virol. 2018;102:39-41.
   PubMed     Text format     Abstract available
   
   
   January 2018
7. KRAWCZYK A, Ackermann J, Goitowski B, Trenschel R, et al
   Assessing the risk of CMV reactivation and reconstitution of antiviral immune response post bone marrow transplantation by the QuantiFERON-CMV-assay and real time PCR.
   J Clin Virol. 2018;99-100:61-66.
   PubMed     Text format     Abstract available
   
   
   December 2017
8. NOBLE J, Gatault P, Sautenet B, Gaudy-Graffin C, et al
   Predictive factors of spontaneous CMV DNAemia clearance in kidney transplantation.
   J Clin Virol. 2017;99-100:38-43.
   PubMed     Text format     Abstract available
   
   
   November 2017
9. CAPRETTI MG, Marsico C, Guidelli Guidi S, Ciardella A, et al
   Neonatal and long-term ophthalmological findings in infants with symptomatic and asymptomatic congenital cytomegalovirus infection.
   J Clin Virol. 2017;97:59-63.
   PubMed     Text format     Abstract available
   
   
   October 2017
10. PAGNON A, Piras F, Gimenez-Fourage S, Dubayle J, et al
    Optimized enzyme-linked immunosorbent assay for detecting cytomegalovirus infections during clinical trials of recombinant vaccines.
    J Clin Virol. 2017;96:99-104.
    PubMed     Text format     Abstract available
    
    
    September 2017
11. GIANNATTASIO A, Di Costanzo P, De Matteis A, Milite P, et al
    Outcomes of congenital cytomegalovirus disease following maternal primary and non-primary infection.
    J Clin Virol. 2017;96:32-36.
    PubMed     Text format     Abstract available
    
    
    
12. GIULIANO M, Pirillo MF, Liotta G, Andreotti M, et al
    High CMV IgG antibody levels are associated to a lower CD4+ RESPONSE to antiretroviral therapy in HIV-infected women.
    J Clin Virol. 2017;96:17-19.
    PubMed     Text format     Abstract available
    
    
    August 2017
13. MASSOUD R, Assi R, Fares E, Haffar B, et al
    Cytomegalovirus reactivation in lymphoma and myeloma patients undergoing autologous peripheral blood stem cell transplantation.
    J Clin Virol. 2017;95:36-41.
    PubMed     Text format     Abstract available
    
    
    
14. ILLIAQUER M, Imbert-Marcille BM, Guillaume T, Planche L, et al
    Impact of stem cell graft on early viral infections and immune reconstitution after allogeneic transplantation in adults.
    J Clin Virol. 2017;93:30-36.
    PubMed     Text format     Abstract available
    
    
    June 2017
15. OMARSDOTTIR S, Agnarsdottir M, Casper C, Orrego A, et al
    High prevalence of cytomegalovirus infection in surgical intestinal specimens from infants with necrotizing enterocolitis and spontaneous intestinal perforation: A retrospective observational study.
    J Clin Virol. 2017;93:57-64.
    PubMed     Text format     Abstract available
    
    
    May 2017
16. SINGH N, Inoue M, Osawa R, Wagener MM, et al
    Inflammasome expression and cytomegalovirus viremia in critically ill patients with sepsis.
    J Clin Virol. 2017;93:8-14.
    PubMed     Text format     Abstract available
    
    
    April 2017
17. GIANNATTASIO A, Di Costanzo P, Milite P, De Martino D, et al
    Is lenticulostriated vasculopathy an unfavorable prognostic finding in infants with congenital cytomegalovirus infection?
    J Clin Virol. 2017;91:31-35.
    PubMed     Text format     Abstract available
    
    
    March 2017
18. LOPEZ-ALADID R, Guiu A, Sanclemente G, Lopez-Medrano F, et al
    Detection of cytomegalovirus drug resistance mutations in solid organ transplant recipients with suspected resistance.
    J Clin Virol. 2017;90:57-63.
    PubMed     Text format     Abstract available
    
    
    
19. BURSTON J, van Hal S, Dubedat S, Lee A, et al
    Inclusions or bystanders? CMV PCR sensitivity and specificity in tissue samples.
    J Clin Virol. 2017;90:38-39.
    PubMed     Text format    
    
    
    
20. SCHAMPERA MS, Schweinzer K, Abele H, Kagan KO, et al
    Comparison of cytomegalovirus (CMV)-specific neutralization capacity of hyperimmunoglobulin (HIG) versus standard intravenous immunoglobulin (IVIG) preparations: Impact of CMV IgG normalization.
    J Clin Virol. 2017;90:40-45.
    PubMed     Text format     Abstract available
    
    
    
21. DELFORGE ML, Costa E, Brancart F, Goldman D, et al
    Presence of Cytomegalovirus in urine and blood of pregnant women with primary infection might be associated with fetal infection.
    J Clin Virol. 2017;90:14-17.
    PubMed     Text format     Abstract available
    
    
    December 2016
22. BRIGHT PD, Gompels M, Donati M, Johnston S, et al
    Successful oral treatment of Ganciclovir resistant cytomegalovirus with Maribavir in the context of primary immunodeficiency: First case report and review.
    J Clin Virol. 2016;87:12-16.
    PubMed     Text format    
    
    
    November 2016
23. JUNG J, Lee HJ, Kim SM, Kang YA, et al
    Diagnostic usefulness of dynamic changes of CMV-specific T-cell responses in predicting CMV infections in HCT recipients.
    J Clin Virol. 2016;87:5-11.
    PubMed     Text format     Abstract available
    
    
    October 2016
24. SCHNEIDER M, Matiqi T, Kundi M, Rieder FJ, et al
    Clinical significance of the single nucleotide polymorphism TLR2 R753Q in heart transplant recipients at risk for cytomegalovirus disease.
    J Clin Virol. 2016;84:64-69.
    PubMed     Text format     Abstract available
    
    
    September 2016
25. CROCCHIOLO R, Giordano L, Rimondo A, Bologna M, et al
    Human Herpesvirus 6 replication predicts Cytomegalovirus reactivation after allogeneic stem cell transplantation from haploidentical donor.
    J Clin Virol. 2016;84:24-26.
    PubMed     Text format     Abstract available
    
    
    August 2016
26. GOELZ R, Hamprecht K, Klingel K, Poets CF, et al
    Intestinal manifestations of postnatal and congenital cytomegalovirus infection in term and preterm infants.
    J Clin Virol. 2016;83:29-36.
    PubMed     Text format     Abstract available
    
    
    
27. ZIELINSKI M, Tarasewicz A, Zielinska H, Jankowska M, et al
    CD28 positive, cytomegalovirus specific cytotoxic T lymphocytes as a novel biomarker associated with cytomegalovirus viremia in kidney allorecipients.
    J Clin Virol. 2016;83:17-25.
    PubMed     Text format     Abstract available
    
    
    July 2016
28. LUCK SE, Emery VC, Atkinson C, Sharland M, et al
    Compartmentalized dynamics of cytomegalovirus replication in treated congenital infection.
    J Clin Virol. 2016;82:152-158.
    PubMed     Text format     Abstract available
    
    
    
29. MORITA S, Shinoda K, Tamaki S, Kono H, et al
    Successful low-dose leflunomide treatment for ganciclovir-resistant cytomegalovirus infection with high-level antigenemia in a kidney transplant: A case report and literature review.
    J Clin Virol. 2016;82:133-138.
    PubMed     Text format     Abstract available
    
    
    
30. ZAVATTONI M, Furione M, Lanzarini P, Arossa A, et al
    Monitoring of human cytomegalovirus DNAemia during primary infection in transmitter and non-transmitter mothers.
    J Clin Virol. 2016;82:89-93.
    PubMed     Text format     Abstract available
    
    
    June 2016
31. MIHM J, Leyking S, Dirks J, Smola S, et al
    Immune-based guidance of foscarnet treatment duration in a transplant recipient with ganciclovir-resistant cytomegalovirus infection.
    J Clin Virol. 2016;82:5-8.
    PubMed     Text format     Abstract available
    
    
    May 2016
32. LILLERI D, Gerna G, Furione M, Zavattoni M, et al
    Neutralizing and ELISA IgG antibodies to human cytomegalovirus glycoprotein complexes may help date the onset of primary infection in pregnancy.
    J Clin Virol. 2016;81:16-24.
    PubMed     Text format     Abstract available
    
    
    April 2016
33. GARRIGUE I, Moulinas R, Recordon-Pinson P, Delacour ML, et al
    Contribution of next generation sequencing to early detection of cytomegalovirus UL97 emerging mutants and viral subpopulations analysis in kidney transplant recipients.
    J Clin Virol. 2016;80:74-81.
    PubMed     Text format     Abstract available
    
    
    
34. GREEN CB, O'Riordan A, Griffiths P, Haque T, et al
    A deletion at CMV UL54 codon 524 without co-existing resistance-associated mutation at UL97 confers resistance to ganciclovir: A case report.
    J Clin Virol. 2016;80:24-26.
    PubMed     Text format     Abstract available
    
    
    
35. LUPO J, Germi R, Jean D, Baccard-Longere M, et al
    Guillain-Barre syndrome and cytomegalovirus infection during pregnancy.
    J Clin Virol. 2016;79:74-76.
    PubMed     Text format     Abstract available
    
    
    
36. LIN X, Wang J, Wang Z, Ru T, et al
    Rare detection of cytomegalovirus in severe fetal malformations in China.
    J Clin Virol. 2016;79:54-60.
    PubMed     Text format     Abstract available
    
    
    March 2016
37. BONO P, Orlandi A, Zoccoli A, Salvatore A, et al
    Quantiferon CMV assay in allogenic stem cell transplant patients.
    J Clin Virol. 2016;79:10-11.
    PubMed     Text format    
    
    
    
38. MENGELLE C, Sandres-Saune K, Mansuy JM, Hasle C, et al
    Performance of a completely automated system for monitoring CMV DNA in plasma.
    J Clin Virol. 2016;79:25-31.
    PubMed     Text format     Abstract available
    
    
    
39. DRAGO F, Javor S, Ciccarese G, Parodi A, et al
    Gianotti-Crosti syndrome as presenting sign of cytomegalovirus infection: A case report and a critical appraisal of its possible cytomegalovirus etiology.
    J Clin Virol. 2016;78:120-122.
    PubMed     Text format     Abstract available
    
    
    
40. DZIECIATKOWSKI T, Tomaszewska A, Przybylski M, Rusicka P, et al
    Analysis of the shedding of three beta-herpesviruses DNA in Polish patients subjected to allogeneic hematopoietic stem cell transplantation: Six-year follow up.
    J Clin Virol. 2016;76:30-5.
    PubMed     Text format     Abstract available
    
    
    February 2016
41. WATT AP, Loughlin L, Coyle PV
    Congenital CMV disease-A female bias in Northern Ireland?
    J Clin Virol. 2016;77:99-100.
    PubMed     Text format    
    
    
    
42. CANTERINO JE, McCormack M, Gurung A, Passarelli J, et al
    Cytomegalovirus appendicitis in an immunocompetent host.
    J Clin Virol. 2016;78:9-11.
    PubMed     Text format     Abstract available
    
    
    
43. ALMANZAR G, Schmalzing M, Trippen R, Hofner K, et al
    Significant IFNgamma responses of CD8+ T cells in CMV-seropositive individuals with autoimmune arthritis.
    J Clin Virol. 2016;77:77-84.
    PubMed     Text format     Abstract available
    
    
    
44. BARGER-KAMATE B, Forman M, Sangare CO, Haidara AS, et al
    Effect of artemether-lumefantrine (Coartem) on cytomegalovirus urine viral load during and following treatment for malaria in children.
    J Clin Virol. 2016;77:40-45.
    PubMed     Text format     Abstract available
    
    
    
45. ALIDJINOU EK, Lazrek M, Libier L, Bocket L, et al
    A patient with fever, abdominal pain and bicytopenia: Trouble once again with these IgM antibodies!
    J Clin Virol. 2016;75:60-3.
    PubMed     Text format     Abstract available
    
    
    December 2015
46. STACHEL D, Stevens-Ayers T, Boeckh M
    In vitro studies of the impact of maribavir on CMV-specific cellular immune responses.
    J Clin Virol. 2015;75:53-59.
    PubMed     Text format     Abstract available
    
    
    
47. CHEN Y, Xu LP, Liu KY, Chen H, et al
    Risk factors for cytomegalovirus DNAemia following haploidentical stem cell transplantation and its association with host hepatitis B virus serostatus.
    J Clin Virol. 2015;75:10-15.
    PubMed     Text format     Abstract available
    
    
    November 2015
48. HERLING M, Schroder L, Awerkiew S, Chakupurakal G, et al
    Persistent CMV infection after allogeneic hematopoietic stem cell transplantation in a CMV-seronegative donor-to-positive recipient constellation: Development of multidrug resistance in the absence of anti-viral cellular immunity.
    J Clin Virol. 2015;74:57-60.
    PubMed     Text format     Abstract available
    
    
    
49. GORZER I, Trajanoski S, Popow-Kraupp T, Puchhammer-Stockl E, et al
    Analysis of human cytomegalovirus strain populations in urine samples of newborns by ultra deep sequencing.
    J Clin Virol. 2015;73:101-104.
    PubMed     Text format     Abstract available
    
    
    September 2015
50. DELFORGE ML, Desomberg L, Montesinos I
    Evaluation of the new LIAISON CMV IgG, IgM and IgG Avidity II assays.
    J Clin Virol. 2015;72:42-45.
    PubMed     Text format     Abstract available
    
    
    
51. SELLIER Y, Guilleminot T, Ville Y, Leruez-Ville M, et al
    Comparison of the LIAISON CMV IgG Avidity II and the VIDAS CMV IgG Avidity II assays for the diagnosis of primary infection in pregnant women.
    J Clin Virol. 2015;72:46-48.
    PubMed     Text format     Abstract available
    
    
    August 2015
52. LAUTENSCHLAGER I, Loginov R, Makisalo H, Hockerstedt K, et al
    Prospective long-term study on primary CMV infections in adult liver transplant (D+/R-) patients after valganciclovir prophylaxis.
    J Clin Virol. 2015;71:73-75.
    PubMed     Text format     Abstract available
    
    
    
53. TAN SK, Waggoner JJ, Pinsky BA
    Cytomegalovirus load at treatment initiation is predictive of time to resolution of viremia and duration of therapy in hematopoietic cell transplant recipients.
    J Clin Virol. 2015;69:179-83.
    PubMed     Text format     Abstract available
    
    
    
54. IKUTA K, Ogawa H, Hashimoto H, Okano W, et al
    Restricted infection of murine cytomegalovirus (MCMV) in neonatal mice with MCMV-induced sensorineural hearing loss.
    J Clin Virol. 2015;69:138-45.
    PubMed     Text format     Abstract available
    
    
    
55. SFEIR M
    Cytomegalovirus implicated in a case of progressive outer retinal necrosis (PORN).
    J Clin Virol. 2015;69:86-90.
    PubMed     Text format     Abstract available
    
    
    July 2015
56. DURANTE-MANGONI E, Andini R, Pinto D, Iossa D, et al
    Effect of the immunosuppressive regimen on the incidence of cytomegalovirus infection in 378 heart transplant recipients: A single centre, prospective cohort study.
    J Clin Virol. 2015;68:37-42.
    PubMed     Text format     Abstract available
    
    
    
57. BERGALLO M, Galliano I, Montanari P, Gambarino S, et al
    CMV induces HERV-K and HERV-W expression in kidney transplant recipients.
    J Clin Virol. 2015;68:28-31.
    PubMed     Text format     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Cytomegalovirus Infection is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: